Please sign in to follow a disease.

Biphenotypic/undifferentiated leukemia

Clinical trials for Biphenotypic/undifferentiated leukemia explained in plain language.

Never miss a new study

Get alerted when new Biphenotypic/undifferentiated leukemia trials appear

Sign up with your email to follow new studies for Biphenotypic/undifferentiated leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Cord blood stem cells boost recovery in High-Risk cancer patients

Disease control Ongoing

This study tests a new stem cell treatment (MGTA-456) made from umbilical cord blood for people with high-risk blood cancers like leukemia and lymphoma. About 22 patients will receive high-dose chemotherapy followed by the stem cell infusion. The goal is to see if this treatment …

Matched conditions: BIPHENOTYPIC/UNDIFFERENTIATED LEUKEMIA

Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

Biphenotypic/undifferentiated leukemia

Get alerted when new Biphenotypic/undifferentiated leukemia trials appear

Cord blood stem cells boost recovery in High-Risk cancer patients